E Panak

COLLABORATIVE OVERVIEW OF RANDOMIZED TRIALS OF ANTIPLATELET THERAPY .1. PREVENTION OF DEATH, MYOCARDIAL-INFARCTION, AND STROKE BY PROLONGED ANTIPLATELET THERAPY IN VARIOUS CATEGORIES OF PATIENTS

Robert Altman, L Carreras, Rubén Sierra Díaz et al. · Oxford University Research Archive (ORA) (University of Oxford) · 1994 · 3.3K citations

Thrombosis, Ischemic Stroke, Cardiovascular Disease +9

THE CANADIAN AMERICAN TICLOPIDINE STUDY (CATS) IN THROMBOEMBOLIC STROKE

Michael Gent, J. Donald Easton, V C Hachinski et al. · The Lancet · 1989 · 910 citations

Thrombosis, Ischemic Stroke, Cardiovascular Disease +10

Ticlopidine: A Promise for the Prevention and Treatment of Thrombosis and Its Complications

E Panak, J.P. Maffrand, C. Picard-Fraire et al. · Pathophysiology of Haemostasis and Thrombosis · 1983 · 129 citations

Thrombosis, Venous Thrombosis, Cardiovascular Disease +10

Considerations for the meta-analysis of randomized clinical trials

Jean‐Pierre Boissel, J Blanchard, E Panak et al. · Controlled Clinical Trials · 1989 · 118 citations

Meta-analysis, Clinical Trial Management, Clinical Trial Analysis +7

Effects of ticlopidine, a new platelet aggregation inhibitor in man

J.J. Thebault, Charles E. Blatrix, J Blanchard et al. · Clinical Pharmacology & Therapeutics · 1975 · 118 citations